| Wed, Jun 17, 2009 | | • | Immunomedics Reports Improved Efficacy With Combination Veltuzumab and Pretargeted Anti-CD20 Radioimmunotherapy in Lymphoma Model
GlobeNewswire (Wed, Jun 17)
| | Tue, Jun 16, 2009 | | • | IMMUNOMEDICS INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Jun 16)
| | • | Immunomedics Reports New Antibody for Pretargeted Imaging and Therapy of Colorectal Cancer
GlobeNewswire (Tue, Jun 16)
| | Mon, Jun 15, 2009 | | • | Immunomedics Reports Improved F-18 Labeling of Peptides for PET Imaging of Tumors
GlobeNewswire (Mon, Jun 15)
| | • | Immunomedics Reports Updated Phase II Results With Radiolabeled Epratuzumab in Non-Hodgkin's Lymphoma
GlobeNewswire (Mon, Jun 15)
| | Fri, Jun 12, 2009 | | • | 5 Cold Stocks Heating Up
at Motley Fool (Fri, Jun 12)
| | Mon, Jun 8, 2009 | | • | Immunomedics to Present At the Society of Nuclear Medicine 56th Annual Meeting
GlobeNewswire (Mon, Jun 8)
| | Fri, Jun 5, 2009 | | • | Immunomedics Reports Updated Results of Low-Dose Veltuzumab for Immune Thrombocytopenic Purpura
GlobeNewswire (Fri, Jun 5)
| | Tue, Jun 2, 2009 | | • | BIOTECHNOLOGY PHASE III TRIALS: MICROCAP PICKS BY INDUSTRY EXPERTS
Wall Street Transcript (Tue, Jun 2)
| | Mon, Jun 1, 2009 | | • | Top Takes From RealMoney
at TheStreet.com (Mon, Jun 1)
| | • | Immunomedics Reports First Efficacy Results of Subcutaneous Humanized Anti-CD20 Antibody Therapy of Lymphoma With Veltuzumab
GlobeNewswire (Mon, Jun 1)
| | • | FDA, Clinical Trial Calendars: Cancer Drug Updates from ASCO
at Seeking Alpha (Mon, Jun 1)
| | Sun, May 31, 2009 | | • | Novel Targeted Radiation Therapy From Immunomedics Produces Objective Responses in Pancreatic Cancer
GlobeNewswire (Sun, May 31)
| | Sat, May 30, 2009 | | • | Immunomedics Reports Updated Results of Milatuzumab in Dose-Escalation Study for Multiple Myeloma
GlobeNewswire (Sat, May 30)
| | Thu, May 28, 2009 | | • | [video] Biotalk: Getting ready for ASCO
at TheStreet.com (Thu, May 28)
| | • | Small-Cap Biotechs Pop Before Conference
at TheStreet.com (Thu, May 28)
| | Tue, May 26, 2009 | | • | Immunomedics' Product Candidates Being Presented At 2009 ASCO Annual Meeting
GlobeNewswire (Tue, May 26)
| | Tue, May 19, 2009 | | • | IMMUNOMEDICS INC Financials
EDGAR Online Financials (Tue, May 19)
| | • | Immunomedics Announces Two New Patent Awards
GlobeNewswire (Tue, May 19)
| | Mon, May 18, 2009 | | • | Final Therapy and Safety Results From Phase I/II Study of Veltuzumab, a Second-Generation Anti-CD20 Humanized Antibody, Published
GlobeNewswire (Mon, May 18)
|
Add IMMU News to My Yahoo!:
 
| |
|
0.06% Nasdaq 0.00%
Headlines
